Six research groups from OUS awarded for publishing excellent articles
In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly. Every half-year, six of the best papers first- or last-authored by scientists working on the hospital are selected. The nomination takes place through the research panel of each division, and the final selection process is performed by an external committee.
In April Oslo University Hospital rewarded six research groups for their excellent papers published during the last half-year of 2013. Each group received NOK 50.000 for use in further research.
The six selected articles are of especially high quality, and they present important finding on both-short and long-term scales. The works reflect the good quality and the interdisciplinarity that characterises several research environments at Oslo University Hospital. The research is a fundamental condition for the institution to maintain and strenghten the quality in the patient treatment, says vice adminestering dirctor Tove Strand, who distributed the prizes on behalf of the hospital.
The articles are nominated by the research panels in the hospitals respective clinics. Then they have been evaluated by an external committee, who have selected the six winners.
|First authors, from left: Jorrit Enserink (and Imre Enserink 4 years old), Kyrre Eeg Emblem, Anna Parente Ribes, Marianne Brodtkorb, Shraddha Kumari, Geir Mjøen. Photo: Ram Gupta
The six articles awarded as winners for the last half-year of 2013:
(presented in random order)
Division of Cancer Medicine, Surgery and Transplantation, Inst. for Cancer Research
Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes.
Kumari S, Wälchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J.
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):403-8. doi: 10.1073/pnas.1306549111. Epub 2013 Dec 16.
First author: Shraddha Kumari, from Johanna Olweus' Immunotherapy and Antigen presentation group at the Institute for Cancer Research
Division of Cancer Medicine, Surgery and Transplantation, Dept. of Transplantation Medicine
Long-term risks for kidney donors.
Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Oyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Ovrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H.
Kidney Int. 2013 Nov 27. doi: 10.1038/ki.2013.460. [Epub ahead of print]
First author: Geir Harald Mjøen
Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma.
Brodtkorb M, Lingjærde OC, Huse K, Trøen G, Hystad M, Hilden VI, Myklebust JH, Leich E, Rosenwald A, Delabie J, Holte H, Smeland EB.
Blood. 2014 Feb 13;123(7):1051-4. doi: 10.1182/blood-2013-07-512392. Epub 2013 Dec 19.
First author: Marianne Brodtkorp, from Erlend B. Smeland's Lymphomas & Lymphocyte biology group, Institute for Cancer Research
Division of Diagnostics and Intervention, Department of Immunology, Centre for Immune Regulation (CIR)
Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
Os A, Bürgler S, Ribes AP, Funderud A, Wang D, Thompson KM, Tjønnfjord GE, Bogen B, Munthe LA.
Cell Rep. 2013 Aug 15;4(3):566-77. doi: 10.1016/j.celrep.2013.07.011. Epub 2013 Aug 8.
First authors: Audun Os, Simone Bürgler, Anna P Ribes (equal first author share), Division of Diagnostics and Intervention, Department of Immunology, Centre for Immune Regulation (CIR)
Division of Diagnostics and Intervention, Department of Radiology and Nuclear Medicine
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.
Emblem KE, Mouridsen K, Bjornerud A, Farrar CT, Jennings D, Borra RJ, Wen PY, Ivy P, Batchelor TT, Rosen BR, Jain RK, Sorensen AG.
Nat Med. 2013 Sep;19(9):1178-83. doi: 10.1038/nm.3289. Epub 2013 Aug 18.
Division of Diagnostics and Invetion, Department of Microbiology
TORC1 inhibits GSK3-mediated Elo2 phosphorylation to regulate very long chain fatty acid synthesis and autophagy.
Zimmermann C, Santos A, Gable K, Epstein S, Gururaj C, Chymkowitch P, Pultz D, Rødkær SV, Clay L, Bjørås M, Barral Y, Chang A, Færgeman NJ, Dunn TM, Riezman H, Enserink JM.
Cell Rep. 2013 Nov 27;5(4):1036-46. doi: 10.1016/j.celrep.2013.10.024. Epub 2013 Nov 14.
Article about the research awards from www.oslo-universitetssykehus.no (in Norwegian):
Fremragende artikler med bredde